Related Experiment Videos
Prejunctional modulation of nitroxidergic nerve function in canine cerebral arteries
N Toda1, M Uchiyama, T Okamura
1Department of Pharmacology, Shiga University of Medical Sciences, Ohtsu, Japan.
Brain Research
|November 27, 1995
Summary
Acetylcholine inhibits nitric oxide (NO) release from canine cerebral arteries via muscarinic receptors. Other tested substances like VIP and clonidine did not affect NO-mediated nerve function.
Area of Science:
- Neuropharmacology
- Vascular Physiology
- Neurotransmission
Background:
- Nitric oxide (NO) is a key neurotransmitter in regulating cerebral blood flow.
- Understanding the modulation of NO release is crucial for managing cerebrovascular tone.
Purpose of the Study:
- To investigate the modulatory effects of various substances on nitroxinergic nerve-mediated relaxation in canine cerebral arteries.
- To elucidate the roles of specific receptors and ions in NO release and vascular response.
Main Methods:
- Isolated canine cerebral arteries were used to study relaxant responses.
- Electrical and chemical nerve stimulation were employed.
- The effects of acetylcholine, VIP, clonidine, omega-conotoxin, Mg2+, and Ca2+ were assessed.
Main Results:
- Acetylcholine inhibited NO-mediated relaxation, an effect reversed by atropine.
- Omega-conotoxin reduced electrically stimulated responses but not nicotine-induced relaxation.
- Magnesium inhibited relaxation, while calcium reversed it, suggesting complex ion-dependent mechanisms.
Conclusions:
- Prejunctional muscarinic receptors appear to inhibit NO synthesis/release.
- Endogenous acetylcholine, VIP, alpha-2 adrenergic, and opioid receptors do not significantly regulate nitroxinergic nerve function.
- Calcium influx via N-type channels (electrical) or non-N-, non-L-type channels (nicotine) is critical for NO synthase activation.